CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics

Circulation Research

Volumn 112, Issue 12, 2013, Pages 1577-1582

  Salmi, Marko ^a,b,c   Karikoski, Marika ^a,b   Elima, Kati ^a   Rantakari, Pia ^a,b   Jalkanen, Sirpa ^a,b,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

endothelium; leukocyte; lymphatics; lymphocytes; migration; traffic

Indexed keywords

CHONDROITIN SULFATE; CYSTEINE; HERMES ANTIGEN; LIGAND; MACROPHAGE MANNOSE RECEPTOR; MANNOSE RECEPTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; IMMUNOPRECIPITATION; IN VIVO STUDY; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC DRAINAGE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ENDOTHELIUM; LEUKOCYTE; LYMPHATICS; LYMPHOCYTES; MIGRATION; TRAFFIC;

ANIMALS; ANTIGENS, CD44; CHEMOTAXIS, LEUKOCYTE; CHONDROITIN SULFATES; ENDOTHELIUM, LYMPHATIC; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; LIGANDS; LYMPH NODES; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TRANSFECTION;

EID: 84880044979     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.300476     Document Type: Article

References (17)

1. Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemela J, Martinez-Pomares L, Salmi M, Jalkanen S. Macrophage mannose receptor on lymphatics controls cell trafficking. Blood. 2008;112:64-72
2. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol. 2005;23:901-944 (Pubitemid 40563189)
3. Kawashima H, Watanabe N, Li YF, Hirose M, Miyasaka M. Characterization of a 180 kDa molecule apparently reactive with recombinant L-selectin. Glycoconj J. 1997;14:321-330 (Pubitemid 27231674)
4. Irjala H, Johansson EL, Grenman R, Alanen K, Salmi M, Jalkanen S. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med. 2001;194:1033-1042
5. Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011;118:6743-6751
6. Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. 1988;141:1615-1623
7. Piepkorn M, Hovingh P, Bennett KL, Aruffo A, Linker A. Chondroitin sulphate composition and structure in alternatively spliced CD44 fusion proteins. Biochem J. 1997;327(pt 2):499-506 (Pubitemid 27477829)
8. Sackstein R. The biology of CD44 and HCELL in hematopoiesis: the "step 2-bypass pathway" and other emerging perspectives. Curr Opin Hematol. 2011;18:239-248
9. Protin U, Schweighoffer T, Jochum W, Hilberg F. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol. 1999;163:4917-4923 (Pubitemid 29501257)
10. Leteux C, Chai W, Loveless RW, Yuen CT, Uhlin-Hansen L, Combarnous Y, Jankovic M, Maric SC, Misulovin Z, Nussenzweig MC, Feizi T. The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J Exp Med. 2000;191:1117-1126 (Pubitemid 30207675)
11. Mummert DI, Takashima A, Mummert ME. Langerhans cells in CD44- deficient mice emigrate from the epidermis but fail to reach the lymph nodes after hapten application. J Invest Dermatol. 2004;122:846-847 (Pubitemid 38471358)
12. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycineaspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 1999;59:219-226 (Pubitemid 29062981)
13. Weiss JM, Renkl AC, Maier CS, Kimmig M, Liaw L, Ahrens T, Kon S, Maeda M, Hotta H, Uede T, Simon JC. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med. 2001;194:1219-1229 (Pubitemid 33055041)
14. Jackson DG. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev. 2009;230:216-231
15. Hertweck MK, Erdfelder F, Kreuzer KA. CD44 in hematological neoplasias. Ann Hematol. 2011;90:493-508
16. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11:254-267
17. Majeti R. Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells. Oncogene. 2011;30:1009-1019.